TP53 and invasive breast carcinoma: A key objective of our study is to identify the functional isoform(s), expression profiles, amplification events, aberrant gene expression mechanisms, and pathways of KDM7A-DT during tumorigenesis and progression of p53 mutation-associated invasive breast cancer subtypes.